Clinical trial

Marker of Brain Insulin Resistance in AD Prognosis

NCT06825663

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-03-15

PhaseNA

Study timeline

Study start (estimated)2025-03-15Date precision: day

Registry last updated2025-02-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prognosis Biomarker of ADunresolved

Mild Cognitive Impairmentunresolved

Brain Insuline Resistanceunresolved

Interventions

Blood punctionBIOLOGICAL

Sponsors & collaborators

Central Hospital, Nancy, Francelead sponsor

Thérèse Jonveauxcollaborator

Laure Jolycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06825663 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.